Last reviewed · How we verify

NCT06811883

Optimising Hip Mobility, Hamstring Flexibility and Performance Using Lightback

Recruiting now NA Last updated 6 February 2025
What this trial tests

NA trial testing LIGHTBACK in Injury;Sports in 20 participants. Currently enrolling.

Timeline
31 January 2025
Primary endpoint
31 March 2025
30 June 2025

Quick facts

Lead sponsorUniversidad Católica de Ávila
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date31 January 2025
Primary completion31 March 2025
Estimated completion30 June 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Católica de Ávila

Who can join

Adults 18 to 65, any sex, with Injury;Sports. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In athletics, in the sprint and hurdles disciplines, muscle injuries account for a significant proportion of injuries. The hamstrings are particularly vulnerable, accounting for between 12% and 26% of all injuries in these sports. A single-blind study was conducted on 20 hurdler patients with the intention of assessing hip mobility, hamstring flexibility and performance. To collect this data, the research team will conduct examinations and interviews with the athletes in two groups: an experimental group using LightBack and a placebo group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Injury;Sports

Currently open trials in the same condition.

Other Universidad Católica de Ávila trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06811883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing